Retraction: microRNA-145 inhibits osteosarcoma cell proliferation and invasion by targeting ROCK1 (Molecular Medicine Reports (2014) 10 (155-160) DOI: 10.3892/mmr.2014.2195);microRNA-145 inhibits osteosarcoma cell proliferation and invasion by targeting ROCK1

Molecular Medicine Reports

Volumn 10, Issue 1, 2014, Pages 155-160

  Lei, Pengfei ^a   Xie, Jie ^a   Wang, Long ^a   Yang, Xucheng ^a   Dai, Zixun ^a   Hu, Yihe ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

Invasion; microRNA 145; Osteosarcoma; Proliferation; Rho associated protein kinase 1

Indexed keywords

MESSENGER RNA; MICRORNA 145; PROTEIN KINASE; RHO ASSOCIATED PROTEIN KINASE 1; UNCLASSIFIED DRUG; 3' UNTRANSLATED REGION; MICRORNA; MIRN145 MICRORNA, HUMAN; RHO KINASE; ROCK1 PROTEIN, HUMAN;

ACTIN FILAMENT; ARTICLE; CANCER INHIBITION; CELL INVASION; CELL PROLIFERATION; CELL PROLIFERATION ASSAY; CONTROLLED STUDY; DOWN REGULATION; HUMAN; HUMAN CELL; IN VITRO STUDY; OSTEOSARCOMA CELL; PROTEIN EXPRESSION; REGULATORY MECHANISM; U2OS CELL LINE; WESTERN BLOTTING; 3' UNTRANSLATED REGION; BONE TUMOR; CELL MOTION; CHEMISTRY; GENETICS; METABOLISM; NUCLEOTIDE SEQUENCE; OSTEOSARCOMA; PATHOLOGY; SEQUENCE ALIGNMENT; TUMOR CELL LINE;

3' UNTRANSLATED REGIONS; BASE SEQUENCE; BONE NEOPLASMS; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; HUMANS; MICRORNAS; OSTEOSARCOMA; RHO-ASSOCIATED KINASES; SEQUENCE ALIGNMENT;

EID: 84901414679     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/MMR.2022.12790     Document Type: Erratum

References (26)

1. Yu X, Wu S, Wang X, Xu M, Xu S and Yuan Y: Late post-operative recurrent osteosarcoma: Three case reports with a review of the literature. Oncol Lett 6: 23-27, 2013.
2. Thompson LD: Osteosarcoma. Ear Nose Throat J 92: 288, 2013.
3. Yang J and Zhang W: New molecular insights into osteosarcoma targeted therapy. Curr Opin Oncol 25: 398-406, 2013.
4. Yates LA, Norbury CJ and Gilbert RJ: The long and short of microRNA. Cell 153: 516-519, 2013.
5. Shukla GC, Singh J and Barik S: MicroRNAs: processing, maturation, target recognition and regulatory functions. Mol Cell Pharmacol 3: 83-92, 2011.
6. Bienertova-Vasku J, Sana J and Slaby O: The role of microRNAs in mitochondria in cancer. Cancer Lett 336: 1-7, 2013.
7. Profumo V and Gandellini P: MicroRNAs: cobblestones on the road to cancer metastasis. Crit Rev Oncog 18: 341-355, 2013.
8. Duan Z, Choy E, Harmon D, et al: MicroRNA-199a-3p is downregulated in human osteosarcoma and regulates cell proliferation and migration. Mol Cancer Ther 10: 1337-1345, 2011.
9. Huang G, Nishimoto K, Zhou Z, Hughes D and Kleinerman ES: miR-20a encoded by the miR-17-92 cluster increases the metastatic potential of osteosarcoma cells by regulating Fas expression. Cancer Res 72: 908-916, 2012.
10. Osaki M, Takeshita F, Sugimoto Y, et al: MicroRNA-143 regulates human osteosarcoma metastasis by regulating matrix metalloprotease-13 expression. Mol Ther 19: 1123-1130, 2011.
11. Campayo M, Navarro A, Viñolas N, et al: Low miR-145 and high miR-367 are associated with unfavourable prognosis in resected nonsmall cell lung cancer. Eur Respir J 41: 1172-1178, 2013.
12. Speranza MC, Frattini V, Pisati F, et al: NEDD9, a novel target of miR-145, increases the invasiveness of glioblastoma. Oncotarget 3: 723-734, 2012.
13. Villadsen SB, Bramsen JB, Ostenfeld MS, et al: The miR-143/-145 cluster regulates plasminogen activator inhibitor-1 in bladder cancer. Br J Cancer 106: 366-374, 2012.
14. Chiyomaru T, Tatarano S, Kawakami K, et al: SWAP70, actin-binding protein, function as an oncogene targeting tumor-suppressive miR-145 in prostate cancer. Prostate: Feb 10, 2011 (Epub ahead of print).
15. Takagi T, Iio A, Nakagawa Y, Naoe T, Tanigawa N and Akao Y: Decreased expression of microRNA-143 and -145 in human gastric cancers. Oncology 77: 12-21, 2009.
16. Zhang W, Wang Q, Yu M, Wu N and Wang H: MicroRNA-145 function as a cell growth repressor by directly targeting c-Myc in human ovarian cancer. Technol Cancer Res Treat: Aug 2, 2013 (Epub ahead of print).
17. Tang M, Lin L, Cai H, Tang J and Zhou Z: MicroRNA-145 downregulation associates with advanced tumor progression and poor prognosis in patients suffering osteosarcoma. Onco Targets Ther 6: 833-838, 2013.
18. Surma M, Wei L and Shi J: Rho kinase as a therapeutic target in cardiovascular disease. Future Cardiol 7: 657-671, 2011.
19. Amano M, Nakayama M and Kaibuchi K: Rho-kinase/ROCK: A key regulator of the cytoskeleton and cell polarity. Cytoskeleton (Hoboken) 67: 545-554, 2010.
20. Li J, Wang J, Jiao H, Liao J and Xu X: Cytokinesis and cancer: Polo loves ROCK'n' Rho(A). J Genet Genomics 37: 159-172, 2010.
21. Liu X, Choy E, Hornicek FJ, et al: ROCK1 as a potential thera peutic target in osteosarcoma. J Orthop Res 29: 1259-1266, 2011.
22. Fan L, Wu Q, Xing X, Wei Y and Shao Z: MicroRNA-145 targets vascular endothelial growth factor and inhibits invasion and metastasis of osteosarcoma cells. Acta Biochim Biophys Sin (Shanghai) 44: 407-414, 2012.
23. Chen RH, Wang WJ and Kuo JC: The tumor suppressor DAP-kinase links cell adhesion and cytoskeleton reorganization to cell death regulation. J Biomed Sci 13: 193-199, 2006.
24. 2+ signaling in T cells. Immunol Rev 232: 319-333, 2009.
25. Hall A: Rho family GTPases. Biochem Soc Trans 40: 1378-1382, 2012.
26. Zhou X, Wei M and Wang W: MicroRNA-340 suppresses osteosarcoma tumor growth and metastasis by directly targeting ROCK1. Biochem Biophys Res, Commun 437: 653-658, 2013.